Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
Jun 26, 2018
| Rachel Schwartz
AAM Statement in Response to Secretary Azar’s Testimony Before Senate Finance Committee
Press Release
Jun 22, 2018
| Rachel Schwartz
AAM Announces Additional 2018 Associate Members
Press Release
Jun 22, 2018
| Rachel Schwartz
AAM Announces New Regular Member and Board Member
Press Release
Jun 14, 2018
| Rachel Schwartz
AAM Statement on Senate Judiciary Committee Vote on CREATES Act
Press Release
Jun 7, 2018
| Rachel Schwartz
IGBA Joins ICH Management Committee and Welcomes the Positive Vote of the General Assembly
Press Release
May 31, 2018
| Rachel Schwartz
AAM Statement on FDA REMS Guidance
Press Release
May 22, 2018
| Rachel Schwartz
AAM Receives Platinum and Gold Recognition from Hermes Creative Awards
Press Release
May 22, 2018
| Rachel Schwartz
AAM Statement on Avalere Medicare Analysis
Press Release
May 18, 2018
| Jeff Francer
AAM Files Brief to Oppose Pharmaceutical Company Abuse of the Patent System
Press Release
May 17, 2018
| Rachel Schwartz
Transparency an Important Step in Ending the Shenanigans
Press Release
May 16, 2018
| Rachel Schwartz
AAM Announces Additional 2018 Associate Members
Press Release
May 14, 2018
| Rachel Schwartz
AAM’s Comments on USTR’s Proposed China Tariffs
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action